(Q38899852)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25772243%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

title

GPNMB cooperates with neuropilin-1 to promote mammary tumor growth and engages integrin α5β1 for efficient breast cancer metastasis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25772243%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

1 reference

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25772243%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Véronique Ouellet

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25772243%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

author name string

G Maric

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25772243%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

M G Annis

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25772243%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Z Dong

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25772243%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

S Ng

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25772243%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

D Perkins

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25772243%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

P A MacDonald

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25772243%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

C Russo

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25772243%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

P M Siegel

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25772243%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

language of work or name

English

0 references

publication date

16 March 2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25772243%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25772243%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

volume

34

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25772243%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

page(s)

5494-5504

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25772243%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

issue

43

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25772243%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/onc.2015.8

2 March 2020

exact match

0 references

cites work

The omics of triple-negative breast cancers

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.8

Molecular characterization of basal-like and non-basal-like triple-negative breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.8

Identification and use of biomarkers in treatment strategies for triple-negative breast cancer subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.8

Glycoprotein nonmetastatic B is an independent prognostic indicator of recurrence and a novel therapeutic target in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.8

The use of an antibody drug conjugate, glembatumumab vedotin (CDX-011), for the treatment of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.8

Phase I/II study of the antibody-drug conjugate glembatumumab vedotin in patients with locally advanced or metastatic breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.8

Osteoactivin promotes breast cancer metastasis to bone

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.8

ADAM10 releases a soluble form of the GPNMB/Osteoactivin extracellular domain with angiogenic properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.8

Osteoactivin fragments produced by ectodomain shedding induce MMP-3 expression via ERK pathway in mouse NIH-3T3 fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.8

Glycoprotein nonmetastatic melanoma protein b, a melanocytic cell marker, is a melanosome-specific and proteolytically released protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.8

Molecular cloning of a dendritic cell-associated transmembrane protein, DC-HIL, that promotes RGD-dependent adhesion of endothelial cells through recognition of heparan sulfate proteoglycans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.8

Osteoactivin is a novel osteoclastic protein and plays a key role in osteoclast differentiation and activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.8

Gpnmb is a melanosome-associated glycoprotein that contributes to melanocyte/keratinocyte adhesion in a RGD-dependent fashion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.8

The Src, Syk, and Tec family kinases: distinct types of molecular switches

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.8

Binding of DC-HIL to dermatophytic fungi induces tyrosine phosphorylation and potentiates antigen presenting cell function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.8

The PKD domain distinguishes the trafficking and amyloidogenic properties of the pigment cell protein PMEL and its homologue GPNMB.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.8

Neuropilins in tumor biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.8

VEGF targets the tumour cell

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.8

Dual role of macrophages in tumor growth and angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.8

Neuropilin-1 upholds dedifferentiation and propagation phenotypes of renal cell carcinoma cells by activating Akt and sonic hedgehog axes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.8

Overexpression of neuropilin-1 promotes constitutive MAPK signalling and chemoresistance in pancreatic cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.8

Integrin control of tumor invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.8

Integrins in cancer: biological implications and therapeutic opportunities

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.8

Neuropilin-1 expression by tumor cells promotes tumor angiogenesis and progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.8

Neuropilin-1 modulates p53/caspases axis to promote endothelial cell survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.8

VEGF exerts an angiogenesis-independent function in cancer cells to promote their malignant progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.8

A synthetic peptide from fibronectin inhibits experimental metastasis of murine melanoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.8

21 January 2018

Integrins and metastasis

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.8

Targeted overexpression of osteoactivin in cells of osteoclastic lineage promotes osteoclastic resorption and bone loss in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.8

Osteoactivin promotes osteoblast adhesion through HSPG and αvβ1 integrin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.8

Distinct recycling of active and inactive β1 integrins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.8

Signals for sorting of transmembrane proteins to endosomes and lysosomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.8

Osteoactivin induces transdifferentiation of C2C12 myoblasts into osteoblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.8

ShcA signalling is essential for tumour progression in mouse models of human breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.8

A complex containing LPP and α-actinin mediates TGFβ-induced migration and invasion of ErbB2-expressing breast cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.8

Distinct phosphotyrosine-dependent functions of the ShcA adaptor protein are required for transforming growth factor β (TGFβ)-induced breast cancer cell migration, invasion, and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.8

Claudin-2 is selectively enriched in and promotes the formation of breast cancer liver metastases through engagement of integrin complexes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.8

An expression signature for p53 status in human breast cancer predicts mutation status, transcriptional effects, and patient survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.8

Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.8

Genomic and transcriptional aberrations linked to breast cancer pathophysiologies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.8

Strong time dependence of the 76-gene prognostic signature for node-negative breast cancer patients in the TRANSBIG multicenter independent validation series

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.8

A gene-expression signature as a predictor of survival in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.8

A multigene predictor of metastatic outcome in early stage hormone receptor-negative and triple-negative breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.8

Management of metastatic breast cancer with second-generation antibody-drug conjugates: focus on glembatumumab vedotin (CDX-011, CR011-vcMMAE).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.8

Expression and regulation of the novel vascular endothelial growth factor receptor neuropilin-1 by epidermal growth factor in human pancreatic carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.8

Expression of class 3 semaphorins and their receptors in human breast neoplasia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.8

The AP-3-dependent targeting of the melanosomal glycoprotein QNR-71 requires a di-leucine-based sorting signal.

31 March 2020

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25772243

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Glycoprotein non-metastatic b (GPNMB): A metastatic mediator and emerging therapeutic target in cancer.

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25772243

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Vascular endothelial growth factor is an autocrine survival factor for neuropilin-expressing breast carcinoma cells

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25772243

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1038/ONC.2015.8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25772243%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

2 March 2020

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25772243%20AND%20SRC:MED&resulttype=core&format=json